Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United States | Publication | December 2022
On December 1, 2022, the Office for Civil Rights (OCR) at the US Department of Health and Human Services (HHS) issued a 12-page Bulletin highlighting the obligations of HIPAA covered entities (including providers and health plans) and business associates that use online tracking technologies on websites or mobile applications. The Bulletin cautions that HIPAA-regulated entities are not permitted to use tracking technologies in a manner that results in impermissible disclosures of protected health information (PHI) to tracking technology vendors or any other violations of the HIPAA Privacy, Security and Breach Notification Rules. To that end, regulated entities must ensure that such disclosures are permitted by the Privacy Rule and enter into a business associate agreement (BAA) with these tracking technology vendors “to ensure PHI is protected in accordance with HIPAA Rules.”
For a detailed overview of the Bulletin, including technical steps you can take, please see the following blog post, "HHS: Online trackers without prior authorization and BAAs can violate HIPAA," produced by Norton Rose Fulbright’s dedicated Information Governance, Privacy and Cybersecurity practice group.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Over the past two years, Spain has significantly strengthened its foreign investment screening mechanism, and all acquisitions by foreign investors (as defined below) of a Spanish entity active in a strategic sector are subject to prior authorisation by the Ministry of Industry, Commerce and Tourism (“MoICT”).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023